| C07051 |
Indinavir |
(P) unclassified |
| D00125 |
Etoposide (JP19/USP/INN); Vepesid (TN) |
(P) unclassified |
| D00140 |
Erythromycin (JP19/USP/INN); Akne-mycin (TN); Eryc (TN); Erygel (TN); Pce (TN); Staticin (TN); T-stat (TN) |
(P) Transporter inhibition: ABCB1 |
| D00168 |
Cytarabine (JP19/USP/INN); ARA-C; Depocyt (TN) |
(P) unclassified |
| D00184 |
Cyclosporine (USP); Ciclosporin (JP19); Gengraf (TN); Neoral (TN); Restasis (TN); Sandimmune (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
| D00208 |
Mitomycin (USP/INN); Mitomycin C (JP19); MMC; Jelmyto (TN); Muamycin (TN) |
(P) unclassified |
| D00210 |
Norfloxacin (JP19/USP/INN); Noroxin (TN) |
(P) unclassified |
| D00211 |
Rifampin (USP); Rifampicin (JP19/INN); Rifadin (TN); Rimactane (TN) |
(CI,P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D00214 |
Dactinomycin (USP); Actinomycin D (JP19); Cosmegen (TN) |
(P) unclassified |
| D00252 |
Carbamazepine (JP19/USP/INN); Equetro (TN); Tegretol (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D00255 |
Carvedilol (JP19/USP/INN); Artist (TN); Coreg (TN) |
(P) Enzyme: CYP3A4 / Transporter inhibition: ABCB1 |
| D00275 |
Cisplatin (JP19/USP/INN); Platinol (TN) |
(P) unclassified |
| D00276 |
Clarithromycin (JP19/USP/INN); Biaxin (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
| D00282 |
Clotrimazole (JP19/USP/INN); Lotrimin (TN); Mycelex (TN) |
(P) CYP inhibition: CYP3A4 |
| D00287 |
Cyclophosphamide (USP); Cyclophosphamide hydrate (JP19); Cytoxan (TN); Neosar (TN) |
(P) Enzyme: CYP3A4 |
| D00288 |
Dacarbazine (JAN/USP/INN); DTIC-Dome (TN) |
(P) unclassified |
| D00292 |
Dexamethasone (JP19/USP/INN); Decadron (TN); Maxidex (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00293 |
Diazepam (JP19/USP/INN); Diastat (TN); Valium (TN) |
(P) Enzyme: CYP3A4 |
| D00295 |
Cimetidine (JP19/USP/INN); Tagamet (TN) |
(P) CYP inhibition: CYP3A4 |
| D00322 |
Fluconazole (JP19/USP/INN); Diflucan (TN) |
(P) CYP inhibition: CYP3A4 |
| D00323 |
Flucytosine (JP19/USP/INN); Ancobon (TN) |
(P) unclassified |
| D00326 |
Fluoxetine (USAN/INN); Fluoxetine (TN) |
(P) Transporter inhibition: ABCB1 |
| D00341 |
Hydroxyurea (USP); Hydroxycarbamide (JAN/INN); Droxia (TN); Hydrea (TN); Siklos (TN) |
(P) unclassified |
| D00343 |
Ifosfamide (JAN/USP/INN); Ifex (TN) |
(P) Enzyme: CYP3A4 |
| D00350 |
Itraconazole (JP19/USP); Itrizole (TN); Sporanox (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
| D00351 |
Ketoconazole (JP19/USP); Nizoral (TN); Xolegel (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
| D00355 |
Lansoprazole (JP19/USP/INN); Prevacid (TN) |
(P) Enzyme: CYP3A4 |
| D00395 |
Troglitazone (JAN/USAN/INN); Rezulin (TN) |
(P) unclassified |
| D00416 |
Miconazole (JP19/USP/INN); Monistat (TN); Oravig (TN) |
(P) unclassified |
| D00420 |
Mitotane (JAN/USP/INN); Lysodren (TN) |
(P) unclassified |
| D00422 |
Ranitidine (USAN/INN) |
(P) unclassified |
| D00424 |
Rifabutin (JAN/USP/INN); Mycobutin (TN) |
(P) Enzyme: CYP3A4 |
| D00427 |
Ritonavir (JAN/USP/INN); Norvir (TN) |
(P) unclassified |
| D00435 |
Nevirapine (JAN/USP/INN); Viramune (TN) |
(P) Enzyme: CYP3A4 |
| D00455 |
Omeprazole (JP19/USP/INN); Prilosec (TN) |
(P) unclassified |
| D00456 |
Ondansetron (JAN/USP/INN); Zofran ODT (TN) |
(P) Enzyme: CYP3A4 |
| D00477 |
Procainamide hydrochloride (JP19/USP); Procan SR (TN); Procanbid (TN); Pronestyl (TN) |
(P) unclassified |
| D00491 |
Paclitaxel (JAN/USP/INN); Abraxane (TN); Taxol (TN) |
(P) Enzyme: CYP3A4 |
| D00506 |
Phenobarbital (JP19/USP/INN); Luminal (TN) |
(P) unclassified |
| D00512 |
Phenytoin (JP19/USP/INN); Dilantin (TN) |
(P) Transporter induction: ABCB1 |
| D00533 |
Oxcarbazepine (JAN/USP/INN); Oxtellar (TN); Trileptal (TN) |
(P) unclassified |
| D00550 |
Midazolam (JAN/USP/INN); Dormicum (TN); Buccolam (TN); Nayzilam (TN) |
(P) Enzyme: CYP3A4 |
| D00554 |
Ethinyl estradiol (USP); Ethinylestradiol (JP19/INN); Estinyl (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00555 |
Amobarbital (JP19/INN); Isomytal (TN) |
(P) unclassified |
| D00578 |
Voriconazole (JP19/USP/INN); Vfend (TN) |
(P) unclassified |
| D00584 |
Fluorouracil (JP19/USP/INN); 5-FU (TN); Adrucil (TN); Carac (TN); Fluoroplex (TN) |
(P) unclassified |
| D00585 |
Mifepristone (JAN/USAN/INN); Korlym (TN); Mifeprex (TN) |
(P) Enzyme: CYP3A4 |
| D00619 |
Verapamil hydrochloride (JP19/USP); Calan (TN); Covera-hs (TN); Vasolan (TN); Verelan (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
| D00636 |
Amiodarone hydrochloride (JP19/USP); Ancaron (TN); Cordarone (TN); Nexterone (TN) |
(P) Enzyme: CYP3A4 |
| D00642 |
Quinidine gluconate (USP); Quinaglute (TN) |
(P) Enzyme: CYP3A4 |
| D00643 |
Quinidine polygalacturonate; Cardioquin (TN) |
(P) Enzyme: CYP3A4 |
| D00673 |
Ranitidine hydrochloride (JP19/USP); Zantac (TN) |
(P) unclassified |
| D00678 |
Ondansetron hydrochloride hydrate (JAN/USP); Ondansetron hydrochloride; Ondansetron hydrochloride dihydrate; Zofran (TN) |
(P) Enzyme: CYP3A4 |
| D00701 |
Phenobarbital sodium (JAN/USP/INN); Luminal sodium (TN) |
(P) unclassified |
| D00707 |
Fomepizole (JAN/USAN/INN); Antizol (TN) |
(P) CYP inhibition: CYP3A4 |
| D00753 |
Sirolimus (JAN/USAN/INN); Rapamune (TN); Rapamycin (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00780 |
Bromocriptine mesylate (USP); Bromocriptine mesilate (JP19); Parlodel (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00823 |
Fluoxetine hydrochloride (JAN/USP); Prozac (TN); Sarafem (TN) |
(P) Transporter inhibition: ABCB1 |
| D00824 |
Fluvoxamine maleate (JP19/USP); Luvox (TN) |
(P) CYP inhibition: CYP3A4 |
| D00831 |
Mefloquine hydrochloride (JP19/USP); Lariam (TN) |
(P) unclassified |
| D00851 |
Erythromycin estolate (USP); Erythromycin estorate (JAN); Ilosone (TN) |
(P) Transporter inhibition: ABCB1 |
| D00854 |
Quinupristin and dalfopristin; Synercid (TN) |
(P) CYP inhibition: CYP3A4 |
| D00879 |
Rifapentine (USAN/INN); Priftin (TN) |
(P) CYP induction: CYP3A4 |
| D00882 |
Miconazole nitrate (JP19/USP); Micatin (TN); Monistat (TN) |
(P) unclassified |
| D00894 |
Amprenavir (JAN/USAN/INN); Agenerase (TN) |
(P) Enzyme: CYP3A4 |
| D00895 |
Delavirdine mesylate (USAN); Delavirdine mesilate (JAN); Rescriptor (TN) |
(P) unclassified |
| D00896 |
Efavirenz (JAN/USP/INN); Sustiva (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00897 |
Indinavir sulfate (USP); Crixivan (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00899 |
Nelfinavir mesylate (USAN/INN); Nelfinavir mesilate (JAN); Viracept (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00960 |
Anastrozole (JP19/USP/INN); Arimidex (TN) |
(P) CYP inhibition: CYP3A4 |
| D00961 |
Bicalutamide (JP19/USP/INN); Casodex (TN) |
(P) CYP inhibition: CYP3A4 |
| D00975 |
Dexamethasone sodium phosphate (JAN/USP); Dalalone (TN); Maxidex (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01059 |
Nimustine hydrochloride (JAN); Nidran (TN) |
(P) unclassified |
| D01061 |
Irinotecan hydrochloride (USP); Irinotecan hydrochloride hydrate (JP19); Irinotecan hydrochloride trihydrate; CPT 11; CPT-11; Campto (TN); Camptosar (TN); Onivyde (TN) |
(P) unclassified |
| D01068 |
Vinblastine sulfate (JP19/USP); Exal (TN); Velban (TN) |
(P) Enzyme: CYP3A4 |
| D01078 |
Telithromycin (JAN/USAN/INN); Ketek (TN) |
(P) unclassified |
| D01155 |
Gemcitabine hydrochloride (JAN/USP); Gemzar (TN) |
(P) unclassified |
| D01211 |
Leucovorin calcium (USP); Calcium folinate (JP19); Uzel (TN); Wellcovorin (TN) |
(P) unclassified |
| D01213 |
Tolvaptan (JP19/USAN/INN); Samsca (TN) |
(P) Enzyme: CYP3A4 / Transporter inhibition: ABCB1 |
| D01227 |
Bosentan (USAN); Bosentan hydrate (JAN); Tracleer (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01235 |
Josamycin (JP19/USAN/INN); Leucomycin A3; JM |
(P) CYP inhibition: CYP3A4 |
| D01236 |
Conivaptan hydrochloride (JAN/USAN); Vaprisol (TN) |
(P) unclassified |
| D01253 |
Clobazam (JAN/USAN/INN); Mystan (TN); Onfi (TN) |
(P) Enzyme: CYP3A4 |
| D01264 |
Daunorubicin hydrochloride (JP19/USP); Cerubidine (TN) |
(P) unclassified |
| D01275 |
Doxorubicin hydrochloride (JP19/USP); Adriacin (TN); Adriamycin (TN); Doxil (TN); Rubex (TN) |
(P) unclassified |
| D01276 |
Atazanavir sulfate (JAN/USAN); Reyataz (TN) |
(P) CYP inhibition: CYP3A4 |
| D01280 |
Warfarin potassium (JP19); Athrombin-K (TN) |
(P) unclassified |
| D01309 |
Doxifluridine (JP19/INN); Furtulon (TN) |
(P) unclassified |
| D01322 |
Troleandomycin (USAN/INN); Triacetyloleandomycin (JAN); TAO; Tao (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D01339 |
Midecamycin (JP19/INN); Medemycin (TN) |
(P) CYP inhibition: CYP3A4 |
| D01361 |
Erythromycin ethylsuccinate (JP19/USP); E.E.S. (TN); Eryped (TN); Erythrocin W (TN) |
(P) Transporter inhibition: ABCB1 |
| D01363 |
Carboplatin (JP19/USP/INN); Paraplatin (TN) |
(P) unclassified |
| D01404 |
Sobuzoxane (JAN); Perazolin (TN) |
(P) unclassified |
| D01416 |
Nedaplatin (JAN/INN); Aqupla (TN) |
(P) unclassified |
| D01425 |
Lopinavir (JAN/USP/INN) |
(P) unclassified |
| D01429 |
Fosfluconazole (JAN/INN); Prodif (TN) |
(P) CYP inhibition: CYP3A4 |
| D01510 |
Dexamethasone metasulfobenzoate sodium (JAN); Dexamethazone metasulfobenzoate sodium; Dexapos; Santeson (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01615 |
Dexamethasone palmitate (JAN); Dexamethasone 21-palmitate; Limethason (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01632 |
Dexamethasone dipropionate (USAN); Dexamethasone propionate (JAN); Hifmeta (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01633 |
Enocitabine (JAN/INN); Sunrabin (TN) |
(P) unclassified |
| D01636 |
Midecamycin acetate (JP19); Miocamycin; Miocamycin (TN) |
(P) CYP inhibition: CYP3A4 |
| D01747 |
Idarubicin hydrochloride (JP19/USP); Idamycin (TN) |
(P) unclassified |
| D01760 |
Ranimustine (JAN/INN); Cymerin (TN) |
(P) unclassified |
| D01769 |
Vindesine sulfate (JAN/USAN); Fildesin (TN) |
(P) unclassified |
| D01790 |
Oxaliplatin (JP19/USP/INN); Eloxatin (TN) |
(P) unclassified |
| D01832 |
Modafinil (JAN/USP/INN); Provigil (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01907 |
Fludarabine phosphate (JAN/USP); Fludara (TN) |
(P) unclassified |
| D01911 |
Aclarubicin hydrochloride (JP19); Aclacinon (TN) |
(P) unclassified |
| D01935 |
Vinorelbine tartrate (USP); Vinorelbine ditartrate (JAN); KW 2307; Navelbine (TN) |
(P) Enzyme: CYP3A4 |
| D01948 |
Dexamethasone valerate (JAN); Dexamethasone 17-valerate; DV-17; Voalla ointment (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01980 |
Luliconazole (JAN/USAN/INN); Lulicon (TN); Luzu (TN) |
(P) CYP inhibition: CYP3A4 |
| D01984 |
Esomeprazole magnesium (USP); Esomeprazole magnesium hydrate (JP19); Esomeprazole magnesium trihydrate; Nexium (TN) |
(P) unclassified |
| D02009 |
Erythromycin lactobionate (JP19/USP); Erythrocin (TN) |
(P) Transporter inhibition: ABCB1 |
| D02096 |
Fosphenytoin sodium (USP); Cerebyx (TN); Sesquient (TN) |
(P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D02102 |
Methadone hydrochloride (JAN/USP); Dolophine hydrochloride (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D02103 |
Phenytoin sodium (USP); Phenytoin sodium for injection (JP19); Aleviatin (TN); Dilantin (TN) |
(P) Transporter induction: ABCB1 |
| D02126 |
Primaquine phosphate (JAN/USP) |
(P) unclassified |
| D02131 |
Tegafur and uracil; Uftoral (TN) |
(P) unclassified |
| D02134 |
Azithromycin hydrate (JP19); Azithromycin dihydrate; Zithromac (TN); Zmax (TN); Azimycin (TN) |
(P) Transporter inhibition: ABCB1 |
| D02165 |
Docetaxel (USP); Docetaxel hydrate (JP19); Docetaxel trihydrate; Taxotere (TN) |
(P) Enzyme: CYP3A4 |
| D02166 |
Mitoxantrone hydrochloride (JAN/USP); Novantron (TN) |
(P) unclassified |
| D02168 |
Topotecan hydrochloride (USAN); Nogitecan hydrochloride (JAN); Hycamtin (TN); Potactasol (TN) |
(P) unclassified |
| D02174 |
Dexamethasone acetate (JAN/USP); Decadronal (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D02177 |
Bleomycin sulfate (JP19/USP); Blenoxane (TN) |
(P) unclassified |
| D02184 |
Erythromycin stearate (JP19/USP); Bristamycin (TN) |
(P) Transporter inhibition: ABCB1 |
| D02197 |
Vincristine sulfate (JP19/USP); VCR; Marqibo (TN); Oncovin (TN); Vincasar (TN); Vincrex (TN) |
(P) unclassified |
| D02214 |
Epirubicin hydrochloride (JP19/USP); EPI; Ellence (TN) |
(P) unclassified |
| D02252 |
Amobarbital sodium (JAN/USP); Amytal sodium (TN) |
(P) unclassified |
| D02272 |
Quinidine sulfate (USP); Quinidine sulfate hydrate (JP19); Quinidex (TN) |
(P) Enzyme: CYP3A4 |
| D02356 |
Verapamil (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
| D02372 |
Perospirone hydrochloride hydrate (JP19); Lullan (TN) |
(P) unclassified |
| D02484 |
Artemether and lumefantrine; Coartem (TN) |
(P) unclassified |
| D02497 |
Fosamprenavir (INN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D02498 |
Lopinavir and ritonavir; Kaletra (TN) |
(P) unclassified |
| D02523 |
Erythromycin acistrate (USAN); Erasis (TN) |
(P) Transporter inhibition: ABCB1 |
| D02524 |
Erythromycin gluceptate (USP); Erythromycin glucoheptonate; Ilotycin gluceptate (TN) |
(P) Transporter inhibition: ABCB1 |
| D02525 |
Erythromycin propionate (USAN) |
(P) Transporter inhibition: ABCB1 |
| D02537 |
Dronedarone (INN) |
(P) Transporter inhibition: ABCB1 |
| D02554 |
Rifaximin (JAN/USAN/INN); Xifaxan (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 / Transporter inhibition: ABCB1 |
| D02555 |
Posaconazole (JAN/USAN/INN); Noxafil (TN) |
(P) CYP inhibition: CYP3A4 |
| D02556 |
Ravuconazole (prop.INN) |
(P) unclassified |
| D02591 |
Dexamethasone acefurate (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D02592 |
Dexamethasone beloxil (USAN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D02691 |
Somatropin (USP/INN); Somatropin (genetical recombination) (JAN); Human growth hormone (JAN); Asellacrin (TN); Humatrope (TN); Nutropin (TN); Omnitrope (TN) |
(P) unclassified |
| D02732 |
Pranlukast hydrate (JP19); Onon (TN) |
(P) Enzyme: CYP3A4 |
| D02861 |
Indinavir sulfate ethanolate (JAN); Crixivan (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D02867 |
Fosamprenavir calcium hydrate (JAN); Lexiva (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D02968 |
Aprepitant (JAN/USP/INN); Aponvie (TN); Emend (TN); Cinvanti (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D03046 |
Cytarabine ocfosfate hydrate (JAN); Cytarabine ocfosphate hydrate; Fosteabine sodium monohydrate; Starasid (TN) |
(P) unclassified |
| D03098 |
Berythromycin (USAN/INN); Erythromycin B |
(P) Transporter inhibition: ABCB1 |
| D03106 |
Bexarotene (JAN/USAN/INN); Targretin (TN) |
(P) unclassified |
| D03165 |
Bromocriptine (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D03229 |
Bleomycin hydrochloride (JP19); BLM; Bleo (TN) |
(P) unclassified |
| D03230 |
Insulin human (USP/INN); Insulin human (genetical recombination) (JP19); Insulin human (biosynthesis) (JAN); Insulin human (synthesis) (JAN); Humulin (TN) |
(P) unclassified |
| D03250 |
Insulin glargine (USAN/INN); Insulin glargine (genetical recombination) (JP19); Insulin glargine (genetical recombination) [Insulin glargin biosimilar 1] (JAN); Insulin glargine (genetical recombination) [Insulin glargin biosimilar 2] (JAN); Insulin glargine-yfgn; Lantus (TN) |
(P) unclassified |
| D03415 |
Carvedilol phosphate (USAN); Carvedilol phosphate hydrate (JAN); Coreg CR (TN) |
(P) Enzyme: CYP3A4 / Transporter inhibition: ABCB1 |
| D03503 |
Cimetidine hydrochloride (USP) |
(P) CYP inhibition: CYP3A4 |
| D03656 |
Darunavir (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D03658 |
Dasatinib (JAN/INN) |
(P) Enzyme: CYP3A4 |
| D03669 |
Deferasirox (JAN/USAN/INN); Exjade (TN); Jadenu (TN) |
(P) CYP induction: CYP3A4 |
| D03833 |
Indinavir (USAN); Indinavir hydrate |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D03835 |
Fosamprenavir calcium (USAN); Lexiva (TN); Telzir (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D03837 |
Fosamprenavir sodium (USAN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D03846 |
Dimethyl fumarate (JAN/USAN); Tecfidera (TN) |
(P) unclassified |
| D03914 |
Dronedarone hydrochloride (USP); Multaq (TN) |
(P) Transporter inhibition: ABCB1 |
| D04024 |
Lapatinib ditosylate (USAN); Lapatinib tosilate hydrate (JAN); Lapatinib ditosylate monohydrate; Tykerb (TN); Tyverb (TN) |
(P) Enzyme: CYP3A4 |
| D04054 |
Erythromycin salnacedin (USAN); Erythromycin salnacedin dihydrate |
(P) Transporter inhibition: ABCB1 |
| D04059 |
Mepenzolate bromide and phenobarbital; Trancolon P (TN) |
(P) unclassified |
| D04112 |
Etravirine (JAN/USAN/INN); Intelence (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 / Transporter inhibition: ABCB1 |
| D04187 |
Fingolimod hydrochloride (JAN/USAN); Gilenya (TN) |
(P) unclassified |
| D04307 |
Proxyphylline, ephedrine hydrochloride and phenobarbital; Asthmolysin D (TN) |
(P) unclassified |
| D04475 |
Insulin aspart (USP/INN); Insulin aspart (genetical recombination) (JP19); Insulin aspart (genetical recombination) [Insulin aspart biosimilar 1] (JAN); Insulin X 14; Insulin aspart-szjj; nsulin aspart-xjhz; Merilog (TN); NovoRapid (TN); Novolog (TN); Kirsty (TN) |
(P) unclassified |
| D04477 |
Insulin lispro (USP/INN); Insulin lispro (genetical recombination) (JAN); Insulin lispro (genetical recombination) [Insulin lispro Biosimilar 1] (JAN); Insulin lispro-aabc; Humalog (TN); Lyumjev (TN) |
(P) unclassified |
| D04539 |
Insulin detemir (USAN/INN); Insulin detemir (genetical recombination) (JAN); Levemir (TN) |
(P) unclassified |
| D04540 |
Insulin glulisine (USAN/INN); Insulin glulisine (genetical recombination) (JAN); Apidra (TN) |
(P) unclassified |
| D04547 |
Insulin, isophane (USP); Isophane insulin (aqueous suspension) (JAN); Humalog PEN (TN) |
(P) unclassified |
| D04641 |
Istradefylline (JAN/USAN/INN); Nourianz (TN); Nouriast (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
| D04666 |
Lanreotide acetate (JAN/USAN); Somatuline (TN) |
(P) unclassified |
| D04768 |
Lonafarnib (JAN/USAN/INN); Zokinvy (TN) |
(P) Transporter inhibition: ABCB1 |
| D05024 |
Mibefradil dihydrochloride (USAN); Posicor (TN) |
(P) unclassified |
| D05152 |
Netupitant (USAN/INN) |
(P) unclassified |
| D05261 |
Omeprazole sodium injection (JAN); Omeprazole sodium hydrate; Omepral (TN) |
(P) unclassified |
| D05351 |
Josamycin propionate (JP19); Josamy (TN) |
(P) CYP inhibition: CYP3A4 |
| D05699 |
Ranitidine bismuth citrate (USAN); Tritec (TN) |
(P) unclassified |
| D05775 |
Rufinamide (JAN/USP/INN); Banzel (TN) |
(P) unclassified |
| D05928 |
Stiripentol (JAN/USAN/INN); Diacomit (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D05932 |
Streptozocin (JAN/USAN/INN); Streptozotocin; Zanosar (TN) |
(P) unclassified |
| D06390 |
Azithromycin (USP); Zmax (TN) |
(P) Transporter inhibition: ABCB1 |
| D06399 |
Tegafur, gimeracil and oteracil potassium; Ts-1 (TN); Teysuno (TN) |
(P) unclassified |
| D06407 |
Vandetanib (JAN/USAN/INN); Caprelsa (TN) |
(P) Enzyme: CYP3A4 / Transporter inhibition: ABCB1 |
| D06413 |
Nilotinib hydrochloride hydrate (JAN); Nilotinib monohydrochloride monohydrate; Tasigna (TN) |
(P) Enzyme: CYP3A4 |
| D06414 |
Dasatinib (USAN); Dasatinib hydrate (JAN); Sprycel (TN) |
(P) Enzyme: CYP3A4 |
| D06478 |
Darunavir ethanolate (JAN); Prezista (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D06503 |
Pemetrexed sodium hydrate (JAN); Pemetrexed disodium heptahydrate; Alimta (TN) |
(P) unclassified |
| D06597 |
Fosaprepitant dimeglumine (USAN); Fosaprepitant meglumine (JAN); Proemend (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D07073 |
Dexamethasone cipecilate (JAN/INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07085 |
Bendamustine hydrochloride (JAN/USAN); Treanda (TN); Ribomustin (TN) |
(P) unclassified |
| D07100 |
Amrubicin hydrochloride (JAN/USAN); Calsed (TN) |
(P) unclassified |
| D07471 |
Atazanavir (INN); Reyataz (TN) |
(P) CYP inhibition: CYP3A4 |
| D07486 |
Azithromycin (INN); Azasite (TN) |
(P) Transporter inhibition: ABCB1 |
| D07538 |
Bosentan (INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07583 |
Phenytoin and phenobarbital; Aleviatin with phenobarbital (TN) |
(P) Transporter induction: ABCB1 |
| D07595 |
Fosphenytoin sodium hydrate (JAN); Fostoin (TN) |
(P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D07710 |
Clarithromycin lactobionate; Klacid (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
| D07748 |
Conivaptan (INN) |
(P) unclassified |
| D07782 |
Delavirdine (INN) |
(P) unclassified |
| D07796 |
Dexamethasone 21-acetate; Dexamethasone acetate anhydrous; Decaject-L.A. (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07797 |
Dexamethasone isonicotinate; Dexamethasone 21-isonicotinate; Voren [veterinary] (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07798 |
Dexamethasone sodium hemisulfate; Dexamethasone 21-sodium sulfate |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07799 |
Dexamethasone 21-tebutate; Dexamethasone tertiary butyl acetate; Dexamedium [veterinary] (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07800 |
Dexamethasone 21-valerate; Voalla (TN); Zalucs (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07801 |
Dexamethasone phenylpropionate; Dexafort [veterinary] (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07802 |
Dexamethasone phosphate; Decadron-phosphate (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07866 |
Docetaxel (JAN/INN); Taxotere (TN) |
(P) Enzyme: CYP3A4 |
| D07909 |
Erythromycin thiocyanate; Erythrocin (TN) |
(P) Transporter inhibition: ABCB1 |
| D07910 |
Erythromycin stinoprate (INN); Erysec (TN) |
(P) Transporter inhibition: ABCB1 |
| D07928 |
Ethinylestradiol propanesulfonate; Turisteron (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D07984 |
Fluvoxamine (INN) |
(P) CYP inhibition: CYP3A4 |
| D07993 |
Fosphenytoin (INN) |
(P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D08080 |
Insulin injection, biphasic isophane (BAN); Biphasic isophane insuline human (genetical recombination) injectable aqueous suspension (JP19); Insulin Humacart (TN) |
(P) unclassified |
| D08195 |
Methadone (BAN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08217 |
Mibefradil (INN) |
(P) unclassified |
| D08259 |
Nelfinavir (INN); Viracept (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D08287 |
Norfloxacin nicotinate; Quinabic soluble powder (TN) [veterinary] |
(P) unclassified |
| D08356 |
Phenobarbital diethylamine; Gratusminal (TN) |
(P) unclassified |
| D08386 |
Pirarubicin hydrochloride; Pinorubin (TN); Therarubicin (TN) |
(P) unclassified |
| D08421 |
Procainamide (INN) |
(P) unclassified |
| D08458 |
Quinidine (BAN) |
(P) Enzyme: CYP3A4 |
| D08459 |
Quinidine phenylethylbarbiturate; Quinidine 5-ethyl 5-phenyl barbiturate; Natisedine (TN) |
(P) Enzyme: CYP3A4 |
| D08479 |
Rifampicin sodium; Rifadine (TN) |
(P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D08616 |
Teneligliptin (INN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D08774 |
Amoxicillin hydrate, clarithromycin and lansoprazole; Lansap (TN); Prevpac (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
| D08837 |
Aclidinium bromide (JAN/USAN/INN); Tudorza (TN); Eklira (TN) |
(P) CYP inhibition: CYP3A4 |
| D08876 |
Boceprevir (INN/USAN); Victrelis (TN) |
(P) unclassified |
| D08914 |
Eribulin mesylate (USAN); Eribulin mesilate (JP19); Halaven (TN) |
(P) Enzyme: CYP3A4 |
| D09012 |
Telaprevir (JAN/USAN/INN); Incivek (TN); Incivo (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
| D09017 |
Ticagrelor (JAN/USAN/INN); Brilinta (TN) |
(P) Transporter inhibition: ABCB1 |
| D09197 |
Valsartan and hydrochlorothiazide (JP19); Co-dio (TN) |
(P) unclassified |
| D09215 |
Eslicarbazepine (USAN/INN) |
(P) CYP induction: CYP3A4 |
| D09347 |
Fostamatinib (USAN) |
(P) Enzyme: CYP3A4 / Transporter inhibition: ABCB1 |
| D09348 |
Fostamatinib disodium (USAN); Fostamatinib sodium hydrate (JAN); Fostamatinib disodium hexahydrate; Tavalisse (TN) |
(P) Enzyme: CYP3A4 / Transporter inhibition: ABCB1 |
| D09394 |
Fidaxomicin (JAN/USAN); Dificid (TN); Dificlir (TN) |
(P) CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
| D09535 |
Mirabegron (JAN/USAN/INN); Myrbetriq (TN) |
(P) Enzyme: CYP3A4 / Transporter inhibition: ABCB1 |
| D09569 |
Ezogabine (USAN); Retigabine (INN); Potiga (TN) |
(P) Transporter inhibition: ABCB1 |
| D09592 |
Canagliflozin (USAN/INN); Canagliflozin hydrate (JAN); Invokana (TN) |
(P) Transporter inhibition: ABCB1 |
| D09612 |
Eslicarbazepine acetate (USAN); Zebinix (TN); Aptiom (TN) |
(P) CYP induction: CYP3A4 |
| D09638 |
Lomitapide mesylate (USAN); Lomitapide mesilate (JAN); Juxtapid (TN); Lojuxta (TN) |
(P) Enzyme: CYP3A4 |
| D09727 |
Insulin degludec (USAN/INN); Insulin degludec (genetical recombination) (JAN); Tresiba (TN) |
(P) unclassified |
| D09731 |
Crizotinib (JAN/USAN/INN); Xalkori (TN) |
(P) Enzyme: CYP3A4 / Transporter inhibition: ABCB1 |
| D09756 |
Teneligliptin hydrobromide hydrate (JAN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D09799 |
Carotegrast methyl (JAN); Carogra (TN) |
(P) CYP inhibition: CYP3A4 |
| D09881 |
Cobicistat (JAN/USAN/INN); Tybost (TN) |
(P) Enzyme-Target: CYP3A4 |
| D09894 |
Eliglustat tartrate (JAN/USAN); Eliglustat hemitartrate; Cerdelga (TN) |
(P) unclassified |
| D09996 |
Vemurafenib (JAN/USAN/INN); Zelboraf (TN) |
(P) CYP induction: CYP3A4 / Transporter inhibition: ABCB1 |
| D10003 |
Hemin (JAN); Normosang (TN); Panhematin (TN) |
(P) CYP induction: CYP3A4 |
| D10064 |
Dabrafenib (USAN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10065 |
Daclatasvir (USAN) |
(P) Enzyme: CYP3A4 |
| D10081 |
Simeprevir (JAN/USAN) |
(P) Transporter inhibition: ABCB1 |
| D10082 |
Suvorexant (JAN/USAN); MK-4305; Belsomra (TN) |
(P) Transporter inhibition: ABCB1 |
| D10093 |
Asunaprevir (JAN/USAN); Sunvepra (TN) |
(P) CYP induction: CYP3A4 / Transporter inhibition: ABCB1 |
| D10104 |
Dabrafenib mesylate (USAN); Dabrafenib mesilate (JAN); Tafinlar (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10105 |
Daclatasvir dihydrochloride (USAN); Daclatasvir hydrochloride (JAN); Daklinza (TN) |
(P) Enzyme: CYP3A4 |
| D10127 |
Glycerol phenylbutyrate (JAN/USAN); Ravicti (TN) |
(P) unclassified |
| D10161 |
Sarilumab (USAN); Sarilumab (genetical receombination) (JAN); Kevzara (TN) |
(P) unclassified |
| D10218 |
Enzalutamide (JAN/USAN); Xtandi (TN) |
(P) unclassified |
| D10246 |
Omeprazole, clarithromycin and amoxicillin; Omeclamox-pak (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
| D10372 |
Palbociclib (JAN/USAN); Ibrance (TN) |
(P) unclassified |
| D10424 |
Lasmiditan succinate (JAN/USAN); lasmiditan hemisuccinate; Reyvow (TN) |
(P) unclassified |
| D10466 |
Vonoprazan fumarate (JAN/USAN); Takecab (TN); Voquezna (TN) |
(P) Enzyme: CYP3A4 |
| D10469 |
Simeprevir sodium (JAN); Olysio (TN); Sovriad (TN) |
(P) Transporter inhibition: ABCB1 |
| D10519 |
Rabeprazole, amoxicillin and clarithromycin; Rabecure (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
| D10526 |
Trifluridine and tipiracil hydrochloride; Lonsurf (TN) |
(P) unclassified |
| D10527 |
Acetylsalicylic acid and lansoprazole; Acetylsalicylic acid and lansoprazole; Takelda (TN) |
(P) Enzyme: CYP3A4 |
| D10551 |
Ceritinib (JAN/USAN/INN); Zykadia (TN) |
(P) unclassified |
| D10564 |
Amenamevir (JAN/INN); Amenalief (TN) |
(P) unclassified |
| D10566 |
Pasireotide pamoate (JAN); Signifor lar (TN) |
(P) unclassified |
| D10570 |
Insulin degludec (genetical recombination) and insulin aspart (genetical recombination); Ryzodeg (TN) |
(P) unclassified |
| D10582 |
Dasabuvir, ombitasvir, paritaprevir and ritonavir; Viekira pak (TN) |
(P) CYP inhibition: CYP3A4 |
| D10596 |
Pemetrexed sodium hemipentahydrate (JAN); Pemetrexed disodium hemipentahydrate |
(P) unclassified |
| D10625 |
Elbasvir (JAN/USAN/INN); Erelsa (TN) |
(P) Transporter inhibition: ABCB1 |
| D10633 |
Finerenone (JAN/USAN/INN); Kerendia (TN) |
(P) Enzyme: CYP3A4 |
| D10639 |
Grazoprevir (USAN); Grazoprevir hydrate (JAN); Grazyna (TN) |
(P) unclassified |
| D10643 |
Isavuconazonium sulfate (JAN/USAN); Cresemba (TN) |
(P) Transporter inhibition: ABCB1 |
| D10644 |
Isavuconazonium (USAN) |
(P) Transporter inhibition: ABCB1 |
| D10679 |
Venetoclax (JAN/USAN/INN); Venclexta (TN) |
(P) unclassified |
| D10727 |
Sodium zirconium cyclosilicate (USAN); Sodium zirconium cyclosilicate hydrate (JAN); Lokelma (TN) |
(P) unclassified |
| D10745 |
Ombitasvir, paritaprevir and ritonavir; Technivie (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
| D10753 |
Atazanavir and cobicistat; Evotaz (TN) |
(P) Enzyme: CYP3A4 / Transporter inhibition: ABCB1 |
| D10755 |
Elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide; Genvoya (TN) |
(P) Transporter inhibition: ABCB1 |
| D10756 |
Elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil; Stribild (TN) |
(P) Transporter inhibition: ABCB1 |
| D10762 |
Fosravuconazole L-lysine ethanolate (JAN) |
(P) unclassified |
| D10766 |
Osimertinib mesylate (USAN); Osimertinib mesilate (JAN); Tagrisso (TN) |
(P) unclassified |
| D10774 |
Vonoprazan, amoxicillin and metronidazole; Vonopion (TN) |
(P) Enzyme: CYP3A4 |
| D10775 |
Vonoprazan, amoxicillin and clarithromycin; Vonosap (TN); Voquenza (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / Transporter inhibition: ABCB1 |
| D10795 |
Elobixibat hydrate (JAN); Goofice (TN) |
(P) Transporter inhibition: ABCB1 |
| D10796 |
Elobixibat (USAN/INN) |
(P) Transporter inhibition: ABCB1 |
| D10801 |
Letermovir (JAN/USAN/INN); Prevymis (TN) |
(P) unclassified |
| D10827 |
Sofosbuvir and velpatasvir; Epclusa (TN) |
(P) Enzyme: CYP3A4 / Transporter inhibition: ABCB1 |
| D10832 |
Darunavir and cobicistat; Prezcobix (TN); Rezolsta (TN) |
(P) Transporter inhibition: ABCB1 |
| D10882 |
Daclatasvir, asunaprevir and beclabuvir; Ximency (TN) |
(P) CYP induction: CYP3A4 / Transporter inhibition: ABCB1 |
| D10891 |
Capmatinib hydrochloride (USAN); Capmatinib hydrochloride hydrate (JAN); Tabrecta (TN) |
(P) Enzyme: CYP3A4 |
| D10895 |
Fosaprepitant (INN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D10897 |
Teneligliptin and canagliflozin; Teneligliptin and canagliflozin; Canalia (TN) |
(P) Enzyme: CYP3A4 / Transporter inhibition: ABCB1 |
| D10926 |
Entrectinib (JAN/USAN/INN); Rozlytrek (TN) |
(P) Enzyme: CYP3A4 |
| D10927 |
Erdafitinib (JAN/USAN/INN); Balversa (TN) |
(P) Enzyme: CYP3A4 / Transporter inhibition: ABCB1 |
| D10931 |
Etrasimod arginine (USAN); Etrasimod L-arginine (JAN); Velsipity (TN) |
(P) Enzyme: CYP3A4 |
| D10990 |
Somatrogon (USAN/INN); Somatrogon (genetical recombination) (JAN); Somatrogon-ghla; Ngenla (TN) |
(P) unclassified |
| D10999 |
Valbenazine tosylate (USAN); Valbenazine tosilate (JAN); Valbenazine ditosylate; Ingrezza (TN); Dysval (TN) |
(P) Enzyme: CYP3A4 |
| D11012 |
Lorlatinib (JAN/USAN/INN); Lorbrena (TN) |
(P) Transporter induction: ABCB1 |
| D11014 |
Glecaprevir and pibrentasvir; Mavyret (TN) |
(P) Transporter inhibition: ABCB1 |
| D11034 |
Insulin glargine and lixisenatide; Insulin glargine (genetical recombination) and lixisenatide; Soliqua (TN) |
(P) unclassified |
| D11040 |
Apalutamide (JAN/INN); Erleada (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D11053 |
Encorafenib (JAN/USAN/INN); Braftovi (TN) |
(P) Enzyme: CYP3A4 |
| D11072 |
Siponimod fumarate (USAN); Siponimod fumaric acid (JAN); Mayzent (TN) |
(P) unclassified |
| D11073 |
Tepotinib hydrochloride (USAN); Tepotinib hydrochloride hydrate (JAN); Tepmetko (TN) |
(P) Enzyme: CYP3A4 |
| D11090 |
Ivosidenib (JAN/USAN/INN); Tibsovo (TN) |
(P) unclassified |
| D11138 |
Larotrectinib sulfate (JAN/USAN); Vitrakvi (TN) |
(P) unclassified |
| D11194 |
Somapacitan (USAN/INN); Somapacitan (genetical recombination) (JAN); Somapacitan-beco; Sogroya (TN) |
(P) unclassified |
| D11208 |
Elafibranor (USAN); Iqirvo (TN) |
(P) CYP induction: CYP3A4 |
| D11273 |
Molidustat sodium (JAN/USAN); Musredo (TN) |
(P) unclassified |
| D11296 |
Fedratinib hydrochloride (USAN); Fedratinib hydrochloride hydrate (JAN); Fedratinib dihydrochloride monohydrate; Inrebic (TN) |
(P) Enzyme: CYP3A4 |
| D11370 |
Fosnetupitant chloride hydrochloride (JAN/USAN); Arokaris (TN) |
(P) unclassified |
| D11371 |
Capivasertib (JAN/USAN); Truqap (TN) |
(P) unclassified |
| D11382 |
Darunavir, cobicistat, emtricitabine and tenofovir alafenamide; Symtuza (TN) |
(P) Transporter inhibition: ABCB1 |
| D11390 |
Daunorubicin and cytarabine; Vyxeos (TN) |
(P) unclassified |
| D11400 |
Abrocitinib (JAN/USAN); Cibinqo (TN) |
(P) unclassified |
| D11404 |
Asciminib hydrochloride (JAN/USAN); Scemblix (TN) |
(P) Enzyme: CYP3A4 |
| D11422 |
Zanubrutinib (JAN/USAN/INN); Brukinsa (TN) |
(P) unclassified |
| D11454 |
Repotrectinib (JAN/USAN); Augtyro (TN) |
(P) Enzyme: CYP3A4 |
| D11485 |
Tazemetostat hydrobromide (JAN/USAN); Tazverik (TN) |
(P) unclassified |
| D11521 |
Lamivudine, nevirapine and zidovudine |
(P) unclassified |
| D11557 |
Tecovirimat hydrate (JAN); Tecovirimat monohydrate; Tpoxx (TN); Tepoxx (TN) |
(P) unclassified |
| D11565 |
Grazoprevir (USAN/INN); Grazoprevir anhydrous |
(P) unclassified |
| D11567 |
Insulin degludec and liraglutide; Xultophy (TN) |
(P) unclassified |
| D11641 |
Danicopan (JAN/USAN/INN); Voydeya (TN) |
(P) unclassified |
| D11661 |
Bendamustine hydrochloride hydrate (JAN); Bendamustine hydrochloride monohydrate; Treakisym (TN) |
(P) unclassified |
| D11662 |
Valemetostat tosilate (JAN); Valemetostat tosylate; Ezharmia (TN) |
(P) unclassified |
| D11673 |
Berotralstat (USAN/INN) |
(P) CYP inhibition: CYP3A4 |
| D11674 |
Berotralstat hydrochloride (JAN/USAN); Orladeyo (TN) |
(P) CYP inhibition: CYP3A4 |
| D11713 |
Selpercatinib (JAN/USAN/INN); Retevmo (TN) |
(P) Enzyme: CYP3A4 |
| D11804 |
Aspirin and vonoprazan; Cabpirin (TN) |
(P) unclassified |
| D11815 |
Belumosudil (USAN) |
(P) Enzyme: CYP3A4 / Transporter inhibition: ABCB1 |
| D11816 |
Belumosudil mesylate (USAN); Belumosudil mesilate (JAN); Rezurock (TN) |
(P) Enzyme: CYP3A4 / Transporter inhibition: ABCB1 |
| D11835 |
Vorasidenib citrate (USAN); Vorasidenib citric acid hydrate (JAN); Voranigo (TN) |
(P) unclassified |
| D11858 |
Omeprazole magnesium, amoxicillin and rifabutin; Talicia (TN) |
(P) unclassified |
| D11887 |
Daridorexant hydrochloride (JAN/USAN); Quviviq (TN) |
(P) unclassified |
| D11920 |
Pimitespib (JAN); Jeselhy (TN) |
(P) unclassified |
| D11954 |
Belzutifan (JAN/USAN/INN); Welireg (TN) |
(P) unclassified |
| D11968 |
Teneligliptin hydrobromide (JAN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D11970 |
Ritlecitinib tosylate (USAN); Ritlecitinib tosilate (JAN); Litfulo (TN) |
(P) unclassified |
| D12015 |
St. John's wort; SJW |
(P) unclassified |
| D12049 |
Camizestrant (JAN/USAN); Etcamah (TN) |
(P) unclassified |
| D12050 |
Pirtobrutinib (JAN/USAN); Jaypirca (TN) |
(P) Enzyme: CYP3A4 / Transporter inhibition: ABCB1 |
| D12055 |
Sotorasib (JAN/USAN); Lumakras (TN) |
(P) unclassified |
| D12217 |
Imlunestrant tosylate (USAN); Imlunestrant tosilate (JAN); Inluriyo (TN) |
(P) Enzyme: CYP3A4 |
| D12245 |
Lazertinib mesylate (USAN); Lazertinib mesilate hydrate (JAN); Lazcluze (TN) |
(P) Enzyme: CYP3A4 |
| D12251 |
Iptacopan (USAN/INN) |
(P) CYP induction: CYP3A4 |
| D12252 |
Iptacopan hydrochloride (USAN); Iptacopan hydrochloride hydrate (JAN); Iptacopan hydrochloride monohydrate; Fabhalta (TN) |
(P) CYP induction: CYP3A4 |
| D12269 |
Nirmatrelvir and ritonavir; Paxlovid (TN) |
(P) Enzyme: CYP3A4 |
| D12353 |
Ensitrelvir fumarate (USAN); Ensitrelvir fumaric acid (JAN); Xocova (TN) |
(P) Transporter inhibition: ABCB1 |
| D12358 |
Insulin icodec (USAN/INN); Insulin icodec (genetical recombination) (JAN); Insulin icodec-abae; Awiqli (TN) |
(P) unclassified |
| D12442 |
Tucatinib ethanolate (JAN); Tucatinib hemiethanolate; Tukysa (TN) |
(P) unclassified |
| D12444 |
Nilotinib hydrochloride dihydrate (JAN) |
(P) Enzyme: CYP3A4 |
| D12586 |
Mifepristone and misoprostol; Mefeego (TN) |
(P) unclassified |
| D12619 |
Ensitrelvir (USAN/INN) |
(P) Transporter inhibition: ABCB1 |
| D12637 |
Darunavir hydrate |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D12752 |
Darunavir propylene glycolate |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D12836 |
Risovalisib (INN) |
(P) unclassified |
| D12837 |
Risovalisib mesilate hydrate (JAN); Risovalisib mesylate dihydrate; Haizexin (TN) |
(P) unclassified |
| D12879 |
Zongertinib (JAN/USAN/INN); Hernexeos (TN) |
(P) unclassified |
| D13245 |
Insulin icodec (genetical recombination) and semaglutide (genetical recombination); Kyinsu (TN) |
(P) unclassified |
